Results of a phase Ib trial examining venetoclax in combination with either rituximab or obinutuzumab plus chemotherapy for treatment of Diffuse Large B-cell lymphoma.
Home / Resource Library / Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial